Lanthanide Bearing Microparticulate Systems for Multi-Modality Imaging and Targeted Therapy of Cancer

ISSN: 1875-5992 (Online)
ISSN: 1871-5206 (Print)


Volume 16, 12 Issues, 2016


Download PDF Flyer




Anti-Cancer Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Cancer Agents

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 27th of 59 in Chemistry, Medicinal

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Michelle Prudhomme
Universite Blaise Pascal - C.N.R.S
Aubiere Cedex
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.722
5 - Year: 2.849

Lanthanide Bearing Microparticulate Systems for Multi-Modality Imaging and Targeted Therapy of Cancer



Anti-Cancer Agents in Medicinal Chemistry, 5(3): 303-313.

Author(s): S. W. Zielhuis, J. F.W. Nijsen, J. H. Seppenwoolde, B. A. Zonnenberg, C. J.G. Bakker, W. E. Hennink, P. P. van Rijk and A D van het Schip.

Affiliation: Department of Nuclear Medicine, room number: E02.222, University Medical Center Utrecht,Heidelberglaan 100, 3584 CX Utrecht, The Netherlands.

Abstract

The rapid developments of high-resolution imaging techniques are offering unique possibilities for the guidance and follow up of recently developed sophisticated anticancer therapies. Advanced biodegradable drug delivery systems, e.g. based on liposomes and polymeric nanoparticles or microparticles, are very effective tools to carry these anticancer agents to their site of action. Elements from the group of lanthanides have very interesting physical characteristics for imaging applications and are the ideal candidates to be co-loaded either in their non-radioactive or radioactive form into these advanced drug delivery systems because of the following reasons: Firstly, they can be used both as magnetic resonance imaging (MRI) and computed tomography (CT) contrast agents and for single photon emission computed tomography (SPECT). Secondly, they can be used for radionuclide therapies which, importantly, can be monitored with SPECT, CT, and MRI. Thirdly, they have a relatively low toxicity, especially when they are complexed to ligands. This review gives a survey of the currently developed lanthanide-loaded microparticulate systems that are under investigation for cancer imaging and/or cancer therapy.

Keywords:

molecular Imaging, lanthanides, cancer therapy, cancer diagnosis, mri, radionuclides, advanced dug, delivery systems.



Purchase Online Order Reprints Order Eprints Rights and Permissions




Article Details

Volume: 5
Issue Number: 3
First Page: 303
Last Page: 313
Page Count: 11
DOI: 10.2174/1568011053765958
Price: $58
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science